Abstract:ABSTRACT Mutations in genes that affect mitochondrial function cause primary mitochondrial diseases. Mitochondrial diseases are highly heterogeneous and even patients with the same mitochondrial disease can exhibit broad phenotypic heterogeneity, which is poorly understood. Mutations in subunits of mitochondrial respiratory complex I cause complex I deficiency, which can result in severe neurological symptoms and death in infancy. However, some complex I deficiency patients present with much milder symptoms. The most common nuclear gene mutated in complex I deficiency is the highly conserved core subunit NDUFS1. To model the phenotypic heterogeneity in complex I deficiency, we used RNAi lines targeting the Drosophila NDUFS1 homolog ND-75 with different efficiencies. Strong knockdown of ND-75 in Drosophila neurons resulted in severe behavioural phenotypes, reduced lifespan, altered mitochondrial morphology, reduced endoplasmic reticulum (ER)-mitochondria contacts and activation of the unfolded protein response (UPR). By contrast, weak ND-75 knockdown caused much milder behavioural phenotypes and changes in mitochondrial morphology. Moreover, weak ND-75 did not alter ER-mitochondria contacts or activate the UPR. Weak and strong ND-75 knockdown resulted in overlapping but distinct transcriptional responses in the brain, with weak knockdown specifically affecting proteosome activity and immune response genes. Metabolism was also differentially affected by weak and strong ND-75 knockdown including gamma-aminobutyric acid (GABA) levels, which may contribute to neuronal dysfunction in ND-75 knockdown flies. Several metabolic processes were only affected by strong ND-75 knockdown including the pentose phosphate pathway and the metabolite 2-hydroxyglutarate (2-HG), suggesting 2-HG as a candidate biomarker of severe neurological mitochondrial disease. Thus, our Drosophila model provides the means to dissect the mechanisms underlying phenotypic heterogeneity in mitochondrial disease.

Unravelling a mechanistic link between mitophagy defect, mitochondrial malfunction, and apoptotic neurodegeneration in MPS VII

Glial lipid droplets and neurodegeneration in a Drosophila model of complex I deficiency

Pathways controlling neurotoxicity and proteostasis in mitochondrial complex I deficiency

Drosophila melanogaster models of MPS IIIC (Hgsnat‐deficiency) highlight the role of glia in disease presentation

Mitophagy modulation rescues single large-scale mitochondrial DNA deletion (SLSMD) disease symptoms in the C. elegans uaDf5 animal model.

Mitochondrial dysfunction drives a neuronal exhaustion phenotype in methylmalonic aciduria

CGG Repeat Expansion in NOTCH2NLC Causes Mitochondrial Dysfunction and Progressive Neurodegeneration in Drosophila Model.

A Drosophila model of mitochondrial disease phenotypic heterogeneity

Mitochondrial Defects in Fibroblasts of Pathogenic MAPT Patients

VCP is Essential for Mitochondrial Quality Control by PINK1/Parkin and This Function is Impaired by VCP Mutations

Metabolic and neurobehavioral disturbances induced by purine recycling deficiency in Drosophila

EDTP/MTMR14: A novel target for improved survivorship to prolonged anoxia and cellular protein aggregates.

Mice Deficient in Epg5 Exhibit Selective Neuronal Vulnerability to Degeneration

Molecular mechanisms of mitophagy and its roles in neurodegenerative diseases

FBXL4: safeguarding against mitochondrial depletion through suppression of mitophagy

Activation of the Keap1/Nrf2 pathway suppresses mitochondrial dysfunction, oxidative stress, and motor phenotypes in C9orf72 ALS/FTD models

Excessive BNIP3-and BNIP3L-dependent Mitophagy Underlies the Pathogenesis of FBXL4-mutated Mitochondrial DNA Depletion Syndrome

Deregulating Mitochondrial Metabolite and Ion Transport Has Beneficial Effects in Yeast and Human Cellular Models for NARP Syndrome

Impaired Mitochondrial Biogenesis Contributes to Depletion of Functional Mitochondria in Chronic MPP+ Toxicity: Dual Roles for ERK1/2

Disruption of Mitophagy Flux through the PARL-PINK1 Pathway by CHCHD10 Mutations or CHCHD10 Depletion